Search

everythinglearnresearchcommunity

for

Search:↓

A new method effectively predicts estrogen-related health effects for early screening.

Pregnancy affects fear memory and brain activity in female rats.

New drugs and therapies targeting specific pathways show promise in treating advanced prostate cancer.

Androgen receptor activity blocks Wnt/β-catenin signaling, affecting hair growth and skin cell balance.

Signals from skin cells controlled by Rac proteins help turn certain precursor cells into white fat cells.

New treatments for cancer and skin disorders show promise in disrupting harmful cell interactions and promoting hair growth.

Male pattern baldness is linked to higher levels of a certain receptor in the scalp, which leads to the shrinking of blood vessels and hair loss. Early treatment targeting this receptor could be more effective.

LPA3 signaling in the uterus is crucial for placental formation and fetal development.

A compound made by Pfizer can potentially stimulate hair growth and reduce oil production, making it a good candidate for topical use.

SARMs show promise but need more evidence to prove they're better than traditional androgens.

The Skin POMC System affects hair growth and skin responses to stress.

The document concludes that adenosine receptor agonists have potential for treating various conditions, but only a few are approved due to challenges like side effects and the need for selective activation.

Blocking CYP17A1 enzyme may help improve certain brain function issues related to dopamine.

Smaller substituents at C-17 enhance the inhibitory activity of progesterone derivatives on 5alpha-reductase.

Cyproterone acetate is used to treat conditions like prostate cancer, early puberty, excessive sexual drive, and female androgenization by blocking male sex hormones.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

Activated ras can protect kidney cells from a certain substance that causes cell death.

Neurosteroids like allopregnanolone help control cell death and growth in the developing fetal brain.

New treatments may restore cancer-blocking proteins, slow prostate cancer, identify drug targets, and potentially regrow hair.

Vitamin D receptor can control the hairless gene linked to hair loss even without vitamin D.

Sex steroids influence skin appendage function and neoplasm development, with changes in AR and ERalpha in certain gland neoplasms.

Female mice with disrupted 5α-reductase 1 had significant metabolic issues, including stress response problems, insulin resistance, liver fat buildup, and obesity.

A specific gene change in APCDD1 increases the risk of hair loss.

RORA may help regulate hair growth by affecting hair follicle stem cells.

G-1 promotes hair growth in female mice by activating specific signaling pathways.

The drug BAY 1158061 is safe, well-tolerated, and shows potential for treating diseases related to prolactin.

Higher CRHR1 levels in AA patients lead to increased inflammation.

Triphenylphosphine oxide can increase oil production and reduce inflammation in skin cells without affecting TRPM5.

Therapies targeting the androgen receptor are being developed to treat prostate cancer and improve bone and muscle health.

AP collagen peptides help hair grow and improve hair health.